Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pullulanase is a specialized debranching enzyme (EC 3.2.1.41) that plays a critical role in the breakdown of complex branched polysaccharides. It specifically targets and hydrolyzes alpha-1,6-glucosidic linkages, which are the branch points in molecules like pullulan and amylopectin, converting them into linear oligosaccharides such as maltotriose (UniProt P07206; PubMed 3025148). While widely utilized in industrial starch processing to increase the yield of fermentable sugars, pullulanase is also a significant factor in microbial pathogenesis. In organisms like Streptococcus mutans and Klebsiella pneumoniae, pullulanase activity contributes to carbohydrate utilization and biofilm stability, making it a potential target for anti-virulence therapies (PubMed 11029450). In human health, pullulanase-like activity is essential for proper digestion; although humans do not produce a standalone pullulanase, the isomaltase subunit of the sucrase-isomaltase complex performs a similar debranching function. Deficiencies in this activity lead to malabsorption syndromes, and exogenous pullulanase is sometimes included in multi-enzyme digestive supplements to aid in the breakdown of dietary starches (StatPearls: Sucrase-Isomaltase Deficiency).
Pullulanase acts as a debranching enzyme by specifically catalyzing the hydrolysis of alpha-1,6-glucosidic bonds in pullulan, amylopectin, and various limit dextrins, thereby facilitating the complete degradation of branched polysaccharides into fermentable sugars.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pullulanase (PUL).